Advertisement
AQB or ATRA or NTLA
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
AQB’s FA Score shows that 0 FA rating(s) are green whileATRA’s FA Score has 0 green FA rating(s), and NTLA’s FA Score reflects 1 green FA rating(s).
- AQB’s FA Score: 0 green, 5 red.
- ATRA’s FA Score: 0 green, 5 red.
- NTLA’s FA Score: 1 green, 4 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
AQB’s TA Score shows that 4 TA indicator(s) are bullish while ATRA’s TA Score has 5 bullish TA indicator(s), and NTLA’s TA Score reflects 2 bullish TA indicator(s).
- AQB’s TA Score: 4 bullish, 5 bearish.
- ATRA’s TA Score: 5 bullish, 5 bearish.
- NTLA’s TA Score: 2 bullish, 6 bearish.
Price Growth
AQB (@Agricultural Commodities/Milling) experienced а -1.40% price change this week, while ATRA (@Biotechnology) price change was +4.94% , and NTLA (@Biotechnology) price fluctuated -10.56% for the same time period.
The average weekly price growth across all stocks in the @Agricultural Commodities/Milling industry was +3.33%. For the same industry, the average monthly price growth was +7.98%, and the average quarterly price growth was -10.43%.
The average weekly price growth across all stocks in the @Biotechnology industry was +0.78%. For the same industry, the average monthly price growth was +90.18%, and the average quarterly price growth was +2050.65%.
Reported Earning Dates
ATRA is expected to report earnings on Aug 10, 2026.
NTLA is expected to report earnings on Jul 30, 2026.
Industries' Descriptions
@Agricultural Commodities/Milling (+3.33% weekly)The Agricultural Commodities/Milling industry includes companies that are involved in farming activities, such as crop production, livestock management and animal feed, for commercial purposes. The industry includes a wide range of operations from growing corn, to grain and oilseed processing to the operation of flour mills. Changes in consumer tastes is one of the critical factors influencing what products are grown and raised in this industry. Potential risks to the business include climate change and fluctuations in global prices of agricultural products. Archer-Daniels-Midland Company, Elanco Animal Health, Inc., Bunge Limited and Canopy Growth Corporation are some of the biggest U.S. companies operating in this industry.
@Biotechnology (+0.78% weekly)Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.
| AQB | ATRA | NTLA | |
| Capitalization | 5.15M | 93.8M | 1.69B |
| EBITDA | -3.49M | -5.48M | -405.09M |
| Gain YTD | 3.903 | -42.454 | 34.705 |
| P/E Ratio | N/A | 3.82 | N/A |
| Revenue | 0 | 23.1M | 66.1M |
| Total Cash | 441K | 8.36M | 376M |
| Total Debt | 3.79M | 10.1M | 80.5M |
AQB | ATRA | NTLA | ||
|---|---|---|---|---|
OUTLOOK RATING 1..100 | 78 | 72 | 68 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 54 Fair valued | 69 Overvalued | 30 Undervalued | |
PROFIT vs RISK RATING 1..100 | 100 | 100 | 100 | |
SMR RATING 1..100 | 100 | 100 | 99 | |
PRICE GROWTH RATING 1..100 | 48 | 45 | 49 | |
P/E GROWTH RATING 1..100 | 100 | 99 | 100 | |
SEASONALITY SCORE 1..100 | 50 | 50 | 75 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
NTLA's Valuation (30) in the Biotechnology industry is in the same range as AQB (54) and is somewhat better than the same rating for ATRA (69). This means that NTLA's stock grew similarly to AQB’s and somewhat faster than ATRA’s over the last 12 months.
NTLA's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as AQB (100) and is in the same range as ATRA (100). This means that NTLA's stock grew similarly to AQB’s and similarly to ATRA’s over the last 12 months.
NTLA's SMR Rating (99) in the Biotechnology industry is in the same range as AQB (100) and is in the same range as ATRA (100). This means that NTLA's stock grew similarly to AQB’s and similarly to ATRA’s over the last 12 months.
ATRA's Price Growth Rating (45) in the Biotechnology industry is in the same range as AQB (48) and is in the same range as NTLA (49). This means that ATRA's stock grew similarly to AQB’s and similarly to NTLA’s over the last 12 months.
ATRA's P/E Growth Rating (99) in the Biotechnology industry is in the same range as AQB (100) and is in the same range as NTLA (100). This means that ATRA's stock grew similarly to AQB’s and similarly to NTLA’s over the last 12 months.
| AQB | ATRA | NTLA | |
|---|---|---|---|
| RSI ODDS (%) | N/A | 2 days ago 90% | N/A |
| Stochastic ODDS (%) | 2 days ago 70% | 2 days ago 85% | 2 days ago 86% |
| Momentum ODDS (%) | 2 days ago 90% | 2 days ago 90% | 2 days ago 86% |
| MACD ODDS (%) | 2 days ago 83% | 2 days ago 85% | 2 days ago 89% |
| TrendWeek ODDS (%) | 2 days ago 88% | 2 days ago 85% | 2 days ago 88% |
| TrendMonth ODDS (%) | 2 days ago 74% | 2 days ago 86% | 2 days ago 90% |
| Advances ODDS (%) | 17 days ago 73% | 3 days ago 86% | 16 days ago 77% |
| Declines ODDS (%) | 2 days ago 89% | 6 days ago 85% | 4 days ago 88% |
| BollingerBands ODDS (%) | 2 days ago 90% | 2 days ago 90% | 2 days ago 90% |
| Aroon ODDS (%) | 2 days ago 90% | 2 days ago 85% | N/A |
Advertisement